These are top 10 stocks traded on the Robinhood UK platform in July
On Wednesday, Citi analyst Vikram Bagri maintained a Neutral rating on Oklo shares (NYSE: OKLO), with a set price target of $30.00. The stock, currently trading at $32.03, sits between analysts’ targets ranging from $30 to $58. According to InvestingPro analysis, the stock appears overvalued at current levels, with 14 additional ProTips available for subscribers. Bagri’s assessment followed Oklo’s initiation of Phase 1 of the pre-application readiness assessment, a crucial step after the completion of site characterization at Idaho National Laboratory (INL). This progress is part of the company’s broader strategy to deploy its initial reactor, expand its isotope business, and establish a commercial-sized fuel fabrication facility. The company, with a market capitalization of $4.45 billion, maintains strong liquidity with a current ratio of 43.47 and holds more cash than debt on its balance sheet.
Oklo anticipates receiving feedback from the Nuclear Regulatory Commission (NRC) shortly, which is expected to assist in navigating potential obstacles before the formal application submission planned for the fourth quarter of 2025. Despite these developments, Oklo’s total backlog, exceeding 14 gigawatts, has remained largely consistent quarter over quarter.
The departure of Sam Altman from Oklo’s Board is seen as an opportunity to potentially enhance discussions with data centers and explore a relationship with OpenAI. Oklo’s Atomic Alchemy™ demonstration lab, projected to cost less than $500,000, is on track to begin generating revenue from early to mid-2026, with a larger facility anticipated to follow in 2028. Additionally, Oklo is making strides in licensing a commercial fuel fabrication site, with the first reactor deployment expected in the late 2027 to early 2028 timeframe. Despite showing impressive year-to-date returns of 50.87%, InvestingPro’s comprehensive analysis reveals both challenges and opportunities ahead, with detailed insights available in the Pro Research Report.
In other recent news, Oklo Inc. reported a slight beat in its Q1 2025 earnings per share (EPS), posting an actual EPS of -$0.07 compared to the forecast of -$0.08. Despite this, the company recorded an operating loss of $17.9 million, reflecting its continued investment in advanced nuclear reactor technology. Oklo is progressing with its Aurora Powerhouse project and has acquired Atomic Alchemy to enhance its radioisotope production capabilities. The company is also expanding its customer pipeline, targeting over 14 gigawatts. In terms of financial health, Oklo ended the quarter with $260.7 million in cash and marketable securities. Analyst firm B. Riley engaged with Oklo’s management, highlighting the company’s strategic fuel agreements, including a memorandum of understanding with Centrus for HALEU supply. Additionally, Oklo was selected as a qualified vendor for the Department of Defense’s Advanced Nuclear Power for Installations program, indicating potential future opportunities with military installations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.